12 Month Follow up in Vivo Icon Study on Fluorotic Teeth
Launched by DMG DENTAL MATERIAL GESELLSCHAFT MBH · Oct 4, 2016
Trial Information
Current as of May 06, 2025
Withdrawn
Keywords
ClinConnect Summary
Dental fluorosis is an endemic public health concern that develops if infants are subjected to excessive amounts of fluoride during enamel formation. Anatomopathologically, dental fluorosis presents itself as a hypermineralized surface layer and subsurface hypomineralization involving the external third of the thickness of the enamel, which is equivalent to early carious lesions. In addition, fluorosis features a number of clinical changes in the enamel surface, ranging from the appearance of thin white lines up to severe structural defects, thereby compromising overall esthetics, which som...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Questionable, Very mild, and Mild (Dean's Index) dental fluorosis as well as TF scale grades 1, 2, and 3 of the upper anterior teeth.
- • Parents of children who accept and commit to the informed consent letter collaborate with the study taking their children to each of the scheduled follow ups.
- Exclusion Criteria:
- • Teeth without fluorosis.
- • Teeth with hypoplasia.
- • Teeth with incipient caries lesions observed at gingival level and differentiated by the Presence of plaque.
- • Teeth previously restored or with aesthetic corrective treatments
- • Teeth with endodontic treatment.
- • Patients with low or questionable hygiene.
- • Malnourished patients or that have some underlying disease.
- • Teeth with less than two thirds of its visible crown.
- • Children that have less than six teeth in their oral cavity.
- • Allergic reaction to methylmethacrylate.
About Dmg Dental Material Gesellschaft Mbh
dmg dental material gesellschaft mbh is a leading manufacturer and innovator in dental materials, dedicated to advancing oral healthcare through research and development. With a commitment to quality and excellence, dmg specializes in a wide range of dental products, including composites, adhesives, and impression materials, designed to enhance clinical outcomes and improve patient experiences. The company actively engages in clinical trials to evaluate the efficacy and safety of its products, ensuring compliance with the highest industry standards and contributing to the advancement of dental technology. Through collaboration with dental professionals and researchers, dmg aims to deliver cutting-edge solutions that meet the evolving needs of the dental community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Ana Armas Vega
Principal Investigator
Universidad Internacional del Ecuador
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials